Formosa Laboratories provides one-stop CDMO services from small-molecule, polymer API, ADC (Antibody Drug Conjugates) manufacturing, formulation development to state-of-art injectable liquid filling and lyophilization for both cytotoxic and non-cytotoxic drug products.
Notably, for over 25 years, Formosa Laboratories has produced its own APIs and UV-filters in its modern facilities in Taiwan. The GMP facilities have been approved by the DOH, FDA, EDQM, PMDA, and German regulatory authorities.